Litcius/Paper detail

The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy

Sashi Kandel, Pratik Adhikary, Guangfu Li, Kun Cheng

2021Cancer Letters161 citationsDOIOpen Access PDF

Topics & Concepts

BlockadeImmune checkpointImmunotherapyCancerCancer researchMedicineCancer immunotherapyImmune systemImmunologyAntibodySignal transductionBiologyReceptorInternal medicineCell biologyGalectins and Cancer BiologyToxin Mechanisms and ImmunotoxinsCancer Mechanisms and Therapy
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy | Litcius